【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 16
1.2 List of Figures 20
2 Introduction 22
2.1 Catalyst 22
2.2 Related Reports 23
2.3 Upcoming Related Reports 24
3 Disease Overview 25
3.1 Overview 25
3.2 Etiology and Pathophysiology 26
3.2.1 Etiology 26
3.2.2 Pathophysiology 33
3.3 Symptoms 35
3.4 Prognosis 36
3.4.1 Phases of Chronic HBV Infection 37
3.4.2 Complications of Chronic Hepatitis B 41
3.5 Quality of Life 43
4 Epidemiology 45
4.1 Disease Background 45
4.2 Risk Factors and Comorbidities 46
4.3 Global Trends 47
4.4 Forecast Methodology 49
4.4.1 Sources Used 50
4.4.2 Sources Not Used 58
4.4.3 Forecast Assumptions and Methods 59
4.5 Epidemiological Forecast of Chronic Hepatitis B (2014-2024) 65
4.5.1 Diagnosed Prevalent Cases of Chronic Hepatitis B 65
4.5.2 Age-Specific Diagnosed Prevalent Cases of Chronic Hepatitis B 67
4.5.3 Sex-Specific Diagnosed Prevalent Cases of Chronic Hepatitis B 70
4.5.4 Age-Standardized Diagnosed Prevalence of Chronic Hepatitis B 72
4.5.5 Diagnosed Prevalent Cases of Chronic Hepatitis B Segmented by HBV DNA Level 74
4.5.6 Diagnosed Prevalent Cases of Chronic Hepatitis B Segmented by ALT Level 75
4.5.7 Diagnosed Prevalent Cases of Chronic Hepatitis B Segmented by HBeAg Status 76
4.5.8 Diagnosed Prevalent Cases of Chronic Hepatitis B Segmented by Cirrhosis Status 77
4.5.9 Diagnosed Prevalent Cases of Chronic Hepatitis B with Co-infection of HIV and Hepatitis C 79
4.6 Discussion 80
4.6.1 Epidemiological Forecast Insight 80
4.6.2 Limitations of the Analysis 80
4.6.3 Strengths of the Analysis 81
5 Disease Management 82
5.1 Diagnosis and Treatment Overview 82
5.1.1 Diagnosis 82
5.1.2 Treatment Guidelines and Leading Prescribed Drugs 83
5.1.3 Clinical Practice 85
5.2 US 90
5.2.1 Screening and Diagnosis 91
5.2.2 Clinical Practice 92
5.3 5EU 95
5.3.1 Screening and Diagnosis 96
5.3.2 Clinical Practice 97
5.4 Japan 101
5.4.1 Screening and Diagnosis 101
5.4.2 Clinical Practice 103
5.5 China 106
5.5.1 Screening and Diagnosis 107
5.5.2 Clinical Practice 109
6 Competitive Assessment 113
6.1 Overview 113
6.2 Product Profiles – Major Brands 117
6.2.1 Baraclude (entecavir) 117
6.2.2 Viread (tenofovir disoproxil fumarate) 122
6.2.3 Pegasys (peginterferon alfa-2a) 130
6.2.4 Hepsera (adefovir dipivoxil) 137
6.2.5 Tyzeka (telbivudine) 141
6.3 Other Therapeutics 147
6.3.1 Conventional and Pegylated Interferon alfa 147
6.3.2 Nucleos(t)ide Analogs 148
7 Unmet Needs and Opportunities 150
7.1 Overview 150
7.2 Improvements in Long-Term Clinical Outcomes 153
7.2.1 Unmet Need 153
7.2.2 Gap Analysis 156
7.2.3 Opportunity 160
7.3 Enhanced Public Awareness and Screening Initiatives to Boost Diagnosis Rates 163
7.3.1 Unmet Need 163
7.3.2 Gap Analysis 167
7.3.3 Opportunity 167
7.4 Increased Access to Treatment 168
7.4.1 Unmet Need 168
7.4.2 Gap Analysis 171
7.4.3 Opportunity 172
7.5 Drugs That Effectively Target and Suppress HBV cccDNA 173
7.5.1 Unmet Need 173
7.5.2 Gap Analysis 173
7.5.3 Opportunity 174
7.6 Safe and Efficacious Therapies for Difficult-to-Treat Patients 175
7.6.1 Unmet Need 175
7.6.2 Gap Analysis 176
7.6.3 Opportunity 177
7.7 Overcome Unique Barriers Posed by China’s Healthcare System 178
7.7.1 Unmet Need 178
7.7.2 Gap Analysis 179
7.7.3 Opportunity 179
8 Pipeline Assessment 181
8.1 Overview 181
8.2 Clinical Trial Mapping 182
8.2.1 Clinical Trials by Phase and Status, Therapy Class, and Location 182
8.3 Promising Drugs in Clinical Development 184
8.3.1 Tenofovir Alafenamide Fumarate 187
8.3.2 ARC-520 194
8.3.3 GS-9620 201
8.3.4 GS-4774 206
8.4 Other Drugs in Development 212
8.4.1 ABX-203 213
8.4.2 REP 2139-Ca 214
8.4.3 Besifovir 215
8.4.4 Hepabulin 215
8.4.5 Myrcludex-B 215
8.4.6 Agents in Early Stages of Development 216
9 Current and Future Players 219
9.1 Overview 219
9.2 Trends in Corporate Strategy 222
9.3 Company Profiles 225
9.3.1 Gilead 225
9.3.2 Bristol-Myers Squibb 227
9.3.3 Roche 229
9.3.4 Merck 230
9.3.5 GSK 233
9.3.6 Novartis 234
9.3.7 Arrowhead Research 235
9.3.8 GlobeImmune 236
10 Market Outlook 237
10.1 Global Markets 237
10.1.1 Forecast 237
10.1.2 Drivers and Barriers – Global Issues 243
10.2 US 245
10.2.1 Forecast 245
10.2.2 Key Events 249
10.2.3 Drivers and Barriers 250
10.3 5EU 252
10.3.1 Forecast 252
10.3.2 Key Events 256
10.3.3 Drivers and Barriers 257
10.4 Japan 260
10.4.1 Forecast 260
10.4.2 Key Events 264
10.4.3 Drivers and Barriers 265
10.5 China 266
10.5.1 Forecast 266
10.5.2 Key Events 270
10.5.3 Drivers and Barriers 271
11 Appendix 274
11.1 Bibliography 274
11.2 Abbreviations 296
11.3 Methodology 302
11.4 Forecasting Methodology 302
11.4.1 Total Prevalent Cases of Chronic Hepatitis B 302
11.4.2 Diagnosed Chronic Hepatitis B Patients 303
11.4.3 Percent Drug-Treated Chronic Hepatitis B Patients 303
11.4.4 Drugs Included in Each Therapeutic Class 304
11.4.5 Launch and Patent Expiry Dates 304
11.4.6 General Pricing Assumptions 305
11.4.7 Individual Drug Assumptions 307
11.4.8 Generic Erosion 314
11.4.9 Pricing of Pipeline Agents 315
11.5 Primary Research – KOLs Interviewed for this Report 316
11.6 Primary Research – Prescriber Survey 319
11.7 About the Authors 320
11.7.1 Analyst 320
11.7.2 Therapy Area Director 320
11.7.3 Epidemiologists 321
11.7.4 Global Director of Therapy Analysis and Epidemiology 321
11.7.5 Global Head of Healthcare 321
11.8 About GlobalData 322
11.9 Disclaimer 322
【レポート販売概要】
■ タイトル：B型肝炎ウイルス（HBV）治療薬の世界市場予測・分析（～2024）■ 英文：PharmaPoint: Hepatitis B Virus (HBV) Therapeutics - Global Drug Forecast and Market Analysis to 2024
■ 発行日：2016年1月1日
■ 調査会社：GlobalData
■ 商品コード：GDHC117PIDR
■ 調査対象地域：グローバル
- 鼻咽頭がん(Nasopharyngeal Cancer)の治療薬パイプライン動向（2015年上半期版）Nasopharyngeal Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Nasopharyngeal Cancer - Pipeline Review, H1 2015’, provides an overview of the Nasopharyngeal Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Nasopharyngeal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug t …
- 水溶性塗料の世界市場：水溶性ペンキ、エマルジョン・ラテックス塗料、アルキド塗料About Waterborne Coatings Waterborne coating is a type of coating, which uses water as a solvent. Water is used as a dispersal agent for resins, thereby making them eco-friendly and easy to use. Water constitutes 80% of the volume of the paint, with traces of other solvents, such as glycol ethers. These coatings are gaining wide application in the US and Western Europe because of their low level o …
- 金属スタンピングの世界市場2019-2023About this market The increasing demand for metal stamping from the APAC region will foster the market growth in the forthcoming years. Favorable government initiatives from the emerging economies including India, China, South Korea, and Taiwan are creating lucrative opportunities for metal stamping products in the region. In addition, the growth of the automotive, electrical and electronics, aero …
- BRIC地域における心臓インターベンション市場動向（～2020）BRIC Interventional Cardiology Market Outlook to 2020 Summary GlobalData’s new report, "BRIC Interventional Cardiology Market Outlook to 2020", provides key market data on the BRIC Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Cathe …
- 世界の対IED防衛市場動向2013-2023：トレンド、開発動向及び課題Technological Developments in the global Counter IED include: ■ The Vehicle Global Acceleration Mitigation (VGAM) and Vehicle Armored Floor Stabilization (VAFS) systems being developed by the UK. ■ Software to predict where IED attacks will take place and locate weapons caches. ■ The US Navy has developed a radio-frequency energy to detonate hidden IEDs. ■ US Navy developing the next generation co …
- 世界のオストミードレナージバッグ(人工瘻排液袋)市場動向（2014-2018）About Ostomy and types of Drainage Bags An ostomy is a surgically made opening (stoma) in the skin that allows the external excretion of waste products such as stools, mucus, and urine into a bag placed outside the body of the patient. This bag is known as an ostomy drainage bag. Ostomies are used for the treatment of intestinal and bladder diseases. These procedures are also used to treat inflamm …
- LTEネットワーク及びM2M通信における無線セキュリティの世界市場The Fourth generation (4G) Long Term Evolution (LTE) standard for cellular communications represents a substantial leap forward in terms of capacity and services capabilities. However, it also presents a unique challenge as its all-IP nature exposes vulnerabilities that were heretofore not substantial concerns. LTE network planners need to address many physical and logical security aspects. For ex …
- スナックペレットの世界市場：ポテト、コーン、米、タピオカ、穀類ミックスThe snack pellets market is growing in accordance with the advancement of the processed food industry. Transforming lifestyles in the urban households of consumers result in increasing dependence on processed food products. Busier lifestyles also induce the need for ready-to-eat snack foods such as snack pellets. Availability of snacks pellets in a variety of shapes, colors, and flavors also attra …
- ソフトウェア定義データセンター（SDDC）の世界市場2017-2021About SDDC SDDC is a data center where all the IT infrastructure is virtualized and delivered as a service. The deployment, provisioning, monitoring, and management of the data center resources are carried out through automated software, which supports enterprise legacy and modern applications. SDDC data centers help in reducing the capital expenditure (CAPEX) and operational expenditure (OPEX) an …
- 2014年戦略提言：フランスの腫瘍マーカー検査市場HighlightsComprehensive 585-page analysis of the French tumor marker testing market.Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, p …
- アンドロイド搭載のスマートフォン及びタブレット市場（モデル別、デザイン別、国及び地域別）2012年第2四半期（Android Smartphones & Tablets Installed Base by Device Model, Form Factor, Country & Region Q2'2012）Covering over 600 Tablets and Smartphones from 63 vendors, this XLS database tracks Android activations by individual device model, form factor, vendor, country and region. The target audience for this report includes handset manufacturers, application developers and mobile network operators. All variants of particular device series are individually covered in the database. As an example, for the …
- 栄養補助食品の世界市場：機能性飲料、機能性食品、ダイエットサプリメントAbout Nutraceuticals The term "nutraceutical" was coined from the words "nutrition" and "pharmaceutical," by Stephen Defelice, in 1989. Defelice was the founder and chairman of the Foundation for Innovation in Medicine, an American organization that encourages medical health discovery. A nutraceutical substance is any food, or part of a food, that provides medical or health benefits and helps in t …
- 工場自動化向けワイヤレス機器の世界市場2015-2019About industrial wireless Wireless devices are used both in process and discrete industries for a wide applications, including easy maintenance, control, and monitoring. These devices are perceived as the next big technological step in industrial automation. However, their adoption has been moderate to date because of concerns over the robustness, reliability, and security of wireless technology. …
- 世界のオレオケミカル脂肪酸市場2015The Global Oleochemical Fatty Acids Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Oleochemical Fatty Acids industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Oleochemical Fatty Acids market analysis is provided for the international markets inclu …
- 世界のモバイル端末用カメラモジュール市場：Global Camera Module in Mobile Device Market 2014-2018TechNavio's analysts forecast the Global Camera Module in Mobile Device market to grow at a CAGR of 13.20 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing adoption of smartphones and tablets. The Global Camera Module in Mobile Device market has also been witnessing rapid advancement in technology. However, the high cost of production co …
